Analysts expect Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Rating) to announce $870.70 million in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Calumet Specialty Products Partners’ earnings. The lowest sales estimate is $856.50 million and the highest is $884.90 million. Calumet Specialty Products Partners posted sales of $600.30 million in the same quarter last year, which suggests a positive year over year growth rate of 45%. The firm is scheduled to announce its next quarterly earnings results on Monday, January 1st.
According to Zacks, analysts expect that Calumet Specialty Products Partners will report full year sales of $3.53 billion for the current year, with estimates ranging from $3.45 billion to $3.61 billion. For the next year, analysts expect that the firm will report sales of $4.14 billion, with estimates ranging from $4.00 billion to $4.28 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Calumet Specialty Products Partners.
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Rating) last announced its earnings results on Friday, February 25th. The oil and gas company reported ($1.08) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.35) by ($0.73). The firm had revenue of $865.80 million for the quarter, compared to the consensus estimate of $810.85 million. During the same period in the prior year, the company posted ($1.03) EPS.
A number of institutional investors and hedge funds have recently made changes to their positions in CLMT. Acadian Asset Management LLC purchased a new position in shares of Calumet Specialty Products Partners during the fourth quarter worth approximately $42,000. Future Financial Wealth Managment LLC purchased a new position in shares of Calumet Specialty Products Partners during the fourth quarter worth approximately $120,000. Dorsey Wright & Associates raised its stake in shares of Calumet Specialty Products Partners by 15.7% during the fourth quarter. Dorsey Wright & Associates now owns 9,014 shares of the oil and gas company’s stock worth $119,000 after acquiring an additional 1,224 shares in the last quarter. J.W. Cole Advisors Inc. bought a new position in shares of Calumet Specialty Products Partners in the third quarter worth approximately $85,000. Finally, Advisor Resource Council bought a new position in shares of Calumet Specialty Products Partners in the fourth quarter worth approximately $159,000. 31.49% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ CLMT traded down $0.45 during trading hours on Friday, reaching $12.64. 3,157 shares of the company were exchanged, compared to its average volume of 204,476. Calumet Specialty Products Partners has a 1 year low of $5.27 and a 1 year high of $17.43. The business’s 50 day simple moving average is $14.52 and its 200-day simple moving average is $13.43.
Calumet Specialty Products Partners Company Profile (Get Rating)
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products.
- Get a free copy of the StockNews.com research report on Calumet Specialty Products Partners (CLMT)
- 3 Undervalued Stocks The Insiders Are Buying
- The Market For Gamestop Is Near A Turning Point
- PayPal Stock is Still Ready for Bargain Hunting
- It’s Personal: 3 Personal Care Stocks to Own in Volatile Markets
- Conagra Stock Has More Room to Grow
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.